195990.KQ Ugint Co Ltd
- Market cap
- KRW 16.7B
- P/E
- -
- P/B
- 0.32x
- ROE
- -14.6%
- Dividend yield
- -
- Fundamental score
- 1.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 195990.KQ undervalued?
Graham numberThe Graham number of Ugint Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ugint Co Ltd fundamental analysis
6 of 21 checks passedROE 0/2
Low return on equity (-14.6%), below 10%.
ROA 0/1
Return on assets (-10.0%) is below the industry median (2.7%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-6,160.0%) is below the industry median (-4.2%).
Revenue Growth 2/2
Revenue grew 13.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (22.9%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Cash Runway 1/2
Cash covers 1.2 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 1/1
Price to book (0.3x) is below the industry median (0.8x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Ugint Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ugint Co Ltd
RootK Co., Ltd. manufactures and sells machine tools and biotechnology products in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. Additionally, It also offers bispecific antibody therapeutics for ophthalmic and oncology indications, including anti-VEGF/ANG2, anti-HER2/CD3, anti-GPC3/CD3, and anti-CLAUDIN18.2/CD3 antibody candidates targeting DME/Wet AMD, breast cancer, gastri…
Full company profileUgint Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ugint Co Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 49.5B | 45.9B | 58.9B | 31.9B | 49.3B | 32.9B | 22.1B | 25.4B | 31.7B | 31.9B | 33.8B |
| Gross Profit | 13.8B | 2.03B | 8.86B | -12.7B | 5.49B | 3.93B | 1.62B | 1.27B | 616M | 3.51B | -797M |
| Operating Income | 947M | -12.2B | -5.06B | -33.8B | -26.7B | -4.96B | -500M | -9.89B | -37.0B | -9.28B | -12.7B |
| EBITDA | - | - | - | - | - | - | -2.15B | -21.4B | -12.5B | -46.3B | -5.44B |
| Net Income | 17.3M | -11.6B | -11.1B | -35.7B | -59.0B | -10.0B | -8.14B | -25.7B | -15.6B | -48.9B | -7.54B |
| EPS | 0.24 | -158 | -112 | -202 | -235 | -39 | -30 | -90 | -55 | -3,437 | -463 |
| Balance Sheet | |||||||||||
| Total Assets | 166B | 172B | 176B | 189B | 166B | 168B | 157B | 142B | 141B | 74.8B | 75.7B |
| Total Liabilities | 56.8B | 74.3B | 69.6B | 70.7B | 26.9B | 30.3B | 16.5B | 19.8B | 33.3B | 20.7B | 23.9B |
| Shareholders' Equity | 110B | 97.6B | 107B | 118B | 139B | 138B | 140B | 122B | 108B | 54.0B | 51.8B |
| Cash & Short-term Investments | 52.7B | 7.55B | 7.03B | 15.0B | 30.9B | 54.0B | 21.0B | 18.9B | 21.2B | 3.90B | 10.8B |
| Total Debt | 11.8B | 17.2B | 9.94B | 13.4B | 11.2B | - | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -10.5B | -34.2B | 2.47B | 2.67B | 2.76B | -2.22B | -12.5B | -4.86B | -5.75B | -6.69B | -9.10B |
| Capital Expenditure | 1.92B | 2.53B | 1.30B | 2.79B | 271M | 542M | 132M | 2.24B | 17.1B | 2.30B | 16.5M |
| Free Cash Flow | - | - | - | 23.7M | 2.11B | -6.01B | -14.8B | -7.10B | -22.9B | -8.99B | -9.12B |
| Ratios | |||||||||||
| ROE | 0.0% | -11.9% | -10.3% | -30.1% | -42.4% | -7.3% | -5.8% | -21.0% | -14.5% | -90.5% | -14.6% |
| ROA | 0.0% | -6.8% | -6.3% | -18.9% | -35.5% | -6.0% | -5.2% | -18.1% | -11.1% | -65.4% | -10.0% |
| Net Profit Margin | 0.0% | -25.3% | -18.8% | -111.8% | -119.7% | -30.5% | -36.8% | -101.4% | -49.4% | -153.2% | -22.3% |
| Debt to Equity | 0.11x | 0.18x | 0.09x | 0.11x | 0.08x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ugint Co Ltd dividends
Ugint Co Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:2 on Jul 30, 2026.
Who owns Ugint Co Ltd
- Insiders 12.61%
- Institutions 0.00%
- Public & others 87.39%
- Shares outstanding 16.3M
- Free float 13.2M
Ugint Co Ltd company profile
- Company name
- Ugint Co Ltd
- Ticker
- 195990.KQ
- ISIN
- KR7195990007
- Exchange
- KOSDAQ
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 35
- Fiscal year end
- December
- Address
- Techno sunhwan-ro 1-gil, Daegu, South Korea, 43022
- Phone
- 82 5 3582 8036
- Website
- abprobio.co.kr
About Ugint Co Ltd
RootK Co., Ltd. manufactures and sells machine tools and biotechnology products in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. Additionally, It also offers bispecific antibody therapeutics for ophthalmic and oncology indications, including anti-VEGF/ANG2, anti-HER2/CD3, anti-GPC3/CD3, and anti-CLAUDIN18.2/CD3 antibody candidates targeting DME/Wet AMD, breast cancer, gastric cancer, and liver cancer.The company was formerly known as Abpro Bio Co., Ltd. and changed its name to RootK Co., Ltd. in June 2026. The company was founded in 1991 and is headquartered in Daegu, South Korea.
Ugint Co Ltd management
4- Mr. Lee Jae-yongCEO & Executive Director · born 1962
- Mr. Ho-jun JangExecutive Director · born 1970
- Mr. Hyung suk KwonExecutive Director · born 1967
- Mr. HoJeong JoExecutive Director · born 1974